Choueiri TK - Search Results

1

PD-1 blockade in renal cell carcinoma: to equilibrium and beyond.

Harshman LC, Drake CG, Choueiri TK. Harshman LC, et al. Among authors: choueiri tk. Cancer Immunol Res. 2014 Dec;2(12):1132-41. doi: 10.1158/2326-6066.CIR-14-0193. Cancer Immunol Res. 2014. PMID: 25480555 Free PMC article. Review.

2

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

3

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

Choueiri TK, Garcia JA, Elson P, Khasawneh M, Usman S, Golshayan AR, Baz RC, Wood L, Rini BI, Bukowski RM. Choueiri TK, et al. Cancer. 2007 Aug 1;110(3):543-50. doi: 10.1002/cncr.22827. Cancer. 2007. PMID: 17577222 Free article.

4

An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications.

Choueiri TK, Baz RC, McFadden CM, Khasawneh M, Karam MA, Kelly M, Hussein MA. Choueiri TK, et al. BJU Int. 2008 Mar;101(6):712-5. doi: 10.1111/j.1464-410X.2007.07268.x. Epub 2007 Oct 26. BJU Int. 2008. PMID: 17970789

5

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

Choueiri TK, Plantade A, Elson P, Negrier S, Ravaud A, Oudard S, Zhou M, Rini BI, Bukowski RM, Escudier B. Choueiri TK, et al. J Clin Oncol. 2008 Jan 1;26(1):127-31. doi: 10.1200/JCO.2007.13.3223. J Clin Oncol. 2008. PMID: 18165647

6

Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agents.

Choueiri TK. Choueiri TK. Clin Genitourin Cancer. 2008 Mar;6(1):15-20. doi: 10.3816/CGC.2008.n.002. Clin Genitourin Cancer. 2008. PMID: 18501077 Review.

7

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.

Rini BI, Choueiri TK, Elson P, Khasawneh MK, Cotta C, Unnithan J, Wood L, Mekhail T, Garcia J, Dreicer R, Bukowski RM. Rini BI, et al. Among authors: choueiri tk. Cancer. 2008 Sep 15;113(6):1309-14. doi: 10.1002/cncr.23711. Cancer. 2008. PMID: 18618496 Free article.

8

von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.

Choueiri TK, Vaziri SA, Jaeger E, Elson P, Wood L, Bhalla IP, Small EJ, Weinberg V, Sein N, Simko J, Golshayan AR, Sercia L, Zhou M, Waldman FM, Rini BI, Bukowski RM, Ganapathi R. Choueiri TK, et al. J Urol. 2008 Sep;180(3):860-5; discussion 865-6. doi: 10.1016/j.juro.2008.05.015. Epub 2008 Jul 17. J Urol. 2008. PMID: 18635227

9

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.

Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK. Choueiri TK, et al. Cancer. 2009 Mar 1;115(5):981-7. doi: 10.1002/cncr.24064. Cancer. 2009. PMID: 19152438 Free PMC article.

10

Optimizing recent advances in metastatic renal cell carcinoma.

Courtney KD, Choueiri TK. Courtney KD, et al. Among authors: choueiri tk. Curr Oncol Rep. 2009 May;11(3):218-26. doi: 10.1007/s11912-009-0031-5. Curr Oncol Rep. 2009. PMID: 19336014 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

790 results

Search Page